Reiner Laus

3.2k total citations · 2 hit papers
24 papers, 2.5k citations indexed

About

Reiner Laus is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Reiner Laus has authored 24 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Reiner Laus's work include Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (6 papers) and RNA Interference and Gene Delivery (4 papers). Reiner Laus is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (6 papers) and RNA Interference and Gene Delivery (4 papers). Reiner Laus collaborates with scholars based in United States and Germany. Reiner Laus's co-authors include Larisa Tsavaler, Michael H. Shapero, Madhusudan V. Peshwa, Frank H. Valone, George Strang, Eric J. Small, David Reese, Curtis Ruegg, Wayne R. Godfrey and William L. Dahut and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and The Journal of Immunology.

In The Last Decade

Reiner Laus

24 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

2010 727 citations Philip W. Kantoff, Reiner Laus et al. Journal of Clinical Oncology profile →
Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins.

2001 509 citations Larisa Tsavaler, Michael H. Shapero et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Reiner Laus United States	16	1.5k	1.1k	930	643	396	24	2.5k
Zhangguo Chen United States	25	1.2k 0.8×	575 0.5×	1.2k 1.2×	100 0.2×	540 1.4×	53	3.0k
Jennifer A. Lo United States	13	1.0k 0.7×	1.3k 1.2×	1.2k 1.3×	173 0.3×	55 0.1×	17	2.5k
Esteban S. Masuda United States	33	1.2k 0.8×	384 0.4×	1.2k 1.3×	136 0.2×	17 0.0×	78	2.6k
Dong Cheng China	26	231 0.2×	513 0.5×	956 1.0×	131 0.2×	61 0.2×	79	1.8k
Tony Avril France	30	1.0k 0.7×	563 0.5×	1.4k 1.5×	187 0.3×	12 0.0×	48	2.8k
Yina H. Huang United States	22	946 0.6×	656 0.6×	523 0.6×	75 0.1×	28 0.1×	55	1.7k
Andrew Craxton United States	25	1.0k 0.7×	313 0.3×	1.1k 1.2×	63 0.1×	14 0.0×	34	2.3k
Youssef Errami United States	20	482 0.3×	832 0.8×	1.1k 1.2×	125 0.2×	29 0.1×	37	1.8k
Sofia Edin Sweden	22	788 0.5×	1.3k 1.2×	816 0.9×	240 0.4×	16 0.0×	38	2.2k
John J. Priatel Canada	23	1.4k 1.0×	391 0.4×	813 0.9×	27 0.0×	43 0.1×	44	2.1k

Countries citing papers authored by Reiner Laus

Since Specialization

Citations

This map shows the geographic impact of Reiner Laus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reiner Laus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reiner Laus more than expected).

Fields of papers citing papers by Reiner Laus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reiner Laus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reiner Laus. The network helps show where Reiner Laus may publish in the future.

Co-authorship network of co-authors of Reiner Laus

This figure shows the co-authorship network connecting the top 25 collaborators of Reiner Laus. A scholar is included among the top collaborators of Reiner Laus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reiner Laus. Reiner Laus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gulley, James L., Nashat Gabrail, Nicholas J. Vogelzang, et al.. (2013). 970 PROSPECT: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 EFFICACY TRIAL OF PROSTVAC-VF IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER. The Journal of Urology. 189(4S). 1 indexed citations

Rountree, Ryan B., Stefanie Mandl, Kay Brinkmann, et al.. (2011). Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy. Cancer Research. 71(15). 5235–5244. 130 indexed citations

Mandl, Stefanie, Ryan B. Rountree, Ulrike Dirmeier, et al.. (2011). Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells. Cancer Immunology Immunotherapy. 61(1). 19–29. 22 indexed citations

Liu, Xiaohui, et al.. (2010). A flow cytometry-based immuno-titration assay for rapid and accurate titer determination of modified vaccinia Ankara virus vectors. Journal of Virological Methods. 169(1). 87–94. 21 indexed citations

Vidović, Damir, Thomas J. Graddis, Lara Stepan, Dennis M. Zaller, & Reiner Laus. (2003). Specific stimulation of MHC-transgenic mouse T-cell hybridomas with xenogeneic APC. Human Immunology. 64(2). 238–244. 9 indexed citations

Diegel, Michael, et al.. (2003). Major Histocompatibility Complex Class I‐Restricted Presentation of Protein Antigens without Prior Intracellular Processing. Scandinavian Journal of Immunology. 58(1). 1–8. 1 indexed citations

Vidović, Damir, Thomas J. Graddis, Feng Chen, et al.. (2002). Antitumor vaccination with HER‐2‐derived recombinant antigens. International Journal of Cancer. 102(6). 660–664. 16 indexed citations

Valone, Frank H., Eric J. Small, Malcolm R. MacKenzie, et al.. (2002). Dendritic cell-based treatment of cancer: closing in on a cellular therapy.. PubMed. 7 Suppl 2. S53–61. 29 indexed citations

Tsavaler, Larisa, et al.. (2001). Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins.. PubMed. 61(9). 3760–9. 509 indexed citations breakdown →

10.

Kundu, Smriti K., et al.. (2000). In Vivo Persistence of Donor Cells following Adoptive Transfer of Allogeneic Dendritic Cells in HIV-Infected Patients. Cell Transplantation. 9(3). 307–317. 11 indexed citations

11.

Laus, Reiner, Thomas J. Graddis, I. Hakim, & Damir Vidović. (2000). Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides. Nature Biotechnology. 18(12). 1269–1272. 31 indexed citations

12.

Small, Eric J., David Reese, George Strang, et al.. (2000). Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells. Journal of Clinical Oncology. 18(23). 3894–3903. 497 indexed citations

13.

Peshwa, Madhusudan V., Jia Shi, Curtis Ruegg, Reiner Laus, & Wim C. A. van Schooten. (1998). Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide. The Prostate. 36(2). 129–138. 102 indexed citations

14.

Fong, Lawrence, Curtis Ruegg, Dirk G. Brockstedt, E G Engleman, & Reiner Laus. (1997). Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer. The Journal of Immunology. 159(7). 3113–3117. 108 indexed citations

15.

Ruegg, Curtis, et al.. (1996). B4B, a novel growth-arrest gene, is expressed by a subset of progenitor/pre-B lymphocytes negative for cytoplasmic mu-chain. The Journal of Immunology. 157(1). 72–80. 24 indexed citations

16.

Ruegg, Curtis, et al.. (1995). V7, a novel leukocyte surface protein that participates in T cell activation. II. Molecular cloning and characterization of the V7 gene.. The Journal of Immunology. 154(9). 4434–4443. 24 indexed citations

17.

Rivas, A, Curtis Ruegg, Reiner Laus, et al.. (1995). V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies.. The Journal of Immunology. 154(9). 4423–4433. 26 indexed citations

18.

Laus, Reiner, et al.. (1992). New parental cell lines for generating human hybridomas. Journal of Immunological Methods. 153(1-2). 21–29. 5 indexed citations

19.

Rivas, A, J Koide, Reiner Laus, & Edgar G. Engleman. (1990). Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules.. The Journal of Immunology. 145(2). 470–476. 22 indexed citations

20.

Laus, Reiner, et al.. (1988). Carbohydrate-Specific Human Heterophile Antibodies in Normal Human Sera That React with Xenogeneic Cells. International Archives of Allergy and Immunology. 85(2). 201–207. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact